Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Critical Reviews in Biomedical Engineering|November 13, 2012
Pharmacokinetic/pharmacodynamic modeling in inflammationHoi-Kei Lon, Dongyang Liu, William J JuskoCritical Reviews in Oncology/Hematology|January 21, 2023
Optimizing benefit/risk in oncology: Review of post-marketing dose optimization and reflections on the road aheadPooneh Soltantabar, Hoi-Kei Lon, Kourosh Parivar, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 1, 2007
Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized miceMelanie A Felmlee, Hoi-Kei Lon, Frank J Gonzalez, et al.Targeted Oncology|August 20, 2025
Elranatamab Fixed Dosing: A Safe, Effective, and Convenient Dosing ApproachMohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma, et al.Oncology and Therapy|March 2, 2026
Summary of Research: Elranatamab Fixed Dosing-A Safe, Effective, and Convenient Dosing ApproachMohamed Elmeliegy, Pooneh Soltantabar, Jennifer Hibma, et al.Therapeutic Innovation & Regulatory Science|September 18, 2018
Oligonucleotide-Based Drug Development: Considerations for Clinical Pharmacology and ImmunogenicityJian Wang, Hoi-Kei Lon, Shwu-Luan Lee, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 16, 2013
Modeling pharmacokinetics/pharmacodynamics of abatacept and disease progression in collagen-induced arthritic rats: a population approachHoi-Kei Lon, Dongyang Liu, Debra C DuBois, et al.Journal of Pharmacokinetics and Pharmacodynamics|October 18, 2011
Population pharmacokinetic-pharmacodynamic-disease progression model for effects of anakinra in Lewis rats with collagen-induced arthritisDongyang Liu, Hoi-Kei Lon, Debra C Dubois, et al.Clinical Therapeutics|February 7, 2021
Pharmacokinetic Comparability of Risankizumab Formulations in Prefilled Syringe and Auto-injector for Subcutaneous InjectionHoi-Kei Lon, Ling Cheng, Sai Nudurupati, et al.Clinical Pharmacology and Therapeutics|March 9, 2024
Impact of Treatment Modality and Route of Administration on Cytokine Release Syndrome in Relapsed or Refractory Multiple Myeloma: A Meta-AnalysisPooneh Soltantabar, Sheena Sharma, Diane Wang, et al.Pageof 3